Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts

Abstract

Rel/NF-κB transcription factors have been implicated in regulating a wide variety of genes important in cellular processes that include cell division, cell survival, differentiation and immunity. Here genetic models in which various Rel/NF-κB and IκB proteins have either been over-expressed or deleted in mice will be reviewed. Although expressed fairly ubiquitously, homozygous disruption of individual Rel/NF-κB genes generally affects the development of proper immune cell function. One exception is rela, which is essential for embryonic liver development. The disruption of genes encoding the individual subunits of the IκB kinase, namely IKKα and IKKβ, has demonstrated that IKKβ transmits the response to most common NF-κB inducing agents, whereas IKKα has an unexpected role in keratinocyte differentiation. Future studies will no doubt focus on the effect of multiple gene disruptions of members of this signaling pathway, on tissue-specific disruptions of these genes, and on the use of these mice as models for human diseases.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Attar RM, Caamaño J, Carrasco D, Iotsova V, Ishikawa H, Ryseck RP, Weih F and Bravo R. . 1997 Semin. Cancer Biol. 8: 93–101.

  • Attar R, Macdonald-Bravo H, Raventos-Suarez SK and Bravo R. . 1998 Mol. Cell. Biol. 18: 477–487.

  • Barkett M and Gilmore TD. . 1999 Oncogene 18: 6910–6924.

  • Beg AA and Baltimore D. . 1996 Science 274: 782–784.

  • Beg AA, Sha WC, Bronson RT and Baltimore D. . 1995 Genes Dev. 9: 2736–2746.

  • Boothby MR, Mora AL, Scherer DC, Brockman JA and Ballard DW. . 1997 J. Exp. Med. 185: 1897–1907.

  • Bours V, Franzoso G, Azareenko V, Park S, Kanno T, Brown K and Siebenlist U. . 1993 Cell 72: 729–739.

  • Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, Olson D, Tizard R, Cate R and Lo D. . 1995 Nature 373: 531–536.

  • Bushdid PB, Brantley DM, Yull FE, Blaeuer GL, Hoffman LH, Niswander L and Kerr LD. . 1998 Nature 392: 615–618.

  • Caamaño JH, Alexander J, Craig L, Bravo R and Hunter CA. . 1999 J. Immunol. in press.

  • Caamaño JH, Perez P, Lira SA and Bravo R. . 1996 Mol. Cell. Biol. 16: 1342–1348.

  • Caamaño JH, Rizzo CA, Durham SK, Barton DS, Raventos-Suarez C, Snapper CM and Bravo R. . 1998 J. Exp. Med. 187: 185–196.

  • Carrasco D, Cheng J, Lewin A, Warr G, Yang H, Rizzo C, Rosas F, Snapper C and Bravo R. . 1998 J. Exp. Med. 187: 973–984.

  • Carrasco D, Perez P, Lewin A and Bravo R. . 1997 J. Exp. Med. 186: 279–288.

  • Carrasco D, Rizzo CA, Dorfman K and Bravo R. . 1996 EMBO J. 15: 3640–3650.

  • Cheng JD, Ryseck RP, Attar RM, Dambach D and Bravo R. . 1998 J. Exp. Med. 188: 1055–1062.

  • Doi TS, Marino MW, Takahashi T, Yoshida T, Sakakura T, Old LJ and Obata Y. . 1999 Proc. Natl. Acad. Sci. USA 96: 2994–2999.

  • Doi TS, Takahashi T, Taguchi O, Azuma T and Obata Y. . 1997 J. Exp. Med. 185: 953–961.

  • Franzoso G, Bours V, Park S, Tomita-Yamaguchi M, Kelly K and Siebenlist U. . 1992 Nature 359: 339–342.

  • Franzoso G, Carlson L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF and Siebenlist U. . 1997 Genes Dev. 11: 3482–3496.

  • Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, Leonardi A, Grinberg A, Tran T, Scharton-Kersten T, Anver M, Love P, Brown K and Siebenlist U. . 1998 J. Exp. Med. 187: 147–159.

  • Gerondakis S, Grumont R, Rourke I and Grossmann M. . 1998 Curr. Opin. Immunol. 10: 353–359.

  • Gerondakis S, Strasser A, Metcalf D, Grigoriadis G, Scheerlinck JY and Grumont RJ. . 1996 Proc. Natl. Acad. Sci. USA 93: 3405–3409.

  • Gilmore TD. . 1999 Oncogene 18: 6925–6937.

  • Govind S. . 1999 Oncogene 18: 6875–6887.

  • Grigoriadis G, Zhan Y, Grumont RJ, Metcalf D, Handman E, Cheers C and Gerondakis S. . 1996 EMBO J. 15: 7099–7107.

  • Grossmann M, Metcalf D, Merryfull J, Beg A, Baltimore D and Gerondakis S. . 1999 Proc. Natl. Acad. Sci. USA in press.

  • Grumont RJ, Rourke IJ and Gerondakis S. . 1999 Genes Dev. 13: 400–411.

  • Grumont RJ, Rourke JJ, O'Reilly LA, Strasser A, Miyake K, Sha W and Gerondakis S. . 1998 J. Exp. Med. 187: 663–674.

  • Harling-McNabb L, Deliyannis G, Jackson DC, Gerondakis S, Grigoriadis G and Brown LE. . 1999 Int. Immunol. 11: 1431–1434.

  • Hettman T, DiDonato J, Karin M and Leiden JM. . 1999 J. Exp. Med. 189: 145–158.

  • Horwitz BH, Scott ML, Cherry SR, Bronson RT and Baltimore D. . 1997 Immunity 6: 765–772.

  • Horwitz BH, Zelazowski P, Shen Y, Wolcott KM, Scott ML, Baltimore D and Snapper CM. . 1999 J. Immunol. 162: 1941–1946.

  • Howard TD, Paznekas WA, Green ED, Chiang LC, Ma N, Ortiz de Luna RI, Garcia Delgado C, Gonzalez-Ramos M, Kline AD and Jabs EW. . 1997 Nature, Genet. 15: 36–41.

  • Hu Y, Baud V, Delhase M, Zhang P, Deeinck T, Ellisman M, Johnson R and Karin M. . 1999 Science 284: 316–320.

  • Inoue J, Kerr LD, Kakizuka A and Verma IM. . 1992 Cell 68: 1109–1120.

  • Iotsova V, Caamaño J, Loy J, Yang Y, Lewin A and Bravo R. . 1997 Nature Med. 3: 1285–1289.

  • Ishikawa H, Carrasco D, Claudio E, Ryseck RP and Bravo R. . 1997 J. Exp. Med. 186: 999–1014.

  • Ishikawa H, Claudio E, Dambach D, Raventos-Suarez C, Ryan C and Bravo R. . 1998 J. Exp. Med. 187: 985–996.

  • Kanegae Y, Taveres AT, Izpisua Belmonte JC and Verma IM. . 1998 Nature 392: 611–614.

  • Klement JF, Rice NR, Car BD, Abbondanzo SJ, Powers GD, Bhatt PH, Chen CH, Rosen CA and Stewart CL. . 1996 Mol. Cell. Biol. 16: 2341–2349.

  • Köntgen F, Grumont RJ, Strasser A, Metcalf D, Li R, Tarlinton D and Gerondakis S. . 1995 Genes Dev. 9: 1965–1977.

  • Li Q, Van Antwerp D, Mercurio F, Lee K-F and Verma IM. . 1999 Science 284: 321–325.

  • Li Z and Nabel GJ. . 1997 Mol. Cell. Biol. 17: 6184–6190.

  • Mémet S, Laouini D, Epinat J-C, Whiteside ST, Goudeau B, Philpott D, Kayal S, Sansonetti PJ, Berche P, Kanellopoulos J and Israël A. . 1999 J. Immunol., in review.

  • Mercurio F and Manning AM. . 1999 Curr. Opin. Cell. Biol. 11: 226–232.

  • Perez P, Lira SA and Bravo R. . 1995 Mol. Cell. Biol. 15: 3523–3520.

  • Rayet B and Gélinas C. . 1999 Oncogene 18: 6938–6947.

  • Schwarz EM, Krimpenfort P, Berns A and Verma IM. . 1997 Genes Dev. 111: 187–197.

  • Seitz CS, Lin Q, Deng H and Khavari PA. . 1998 Proc. Natl. Acad. Sci. USA 95: 2307–2312.

  • Sha WC, Liou HC, Tuomanen EI and Baltimore D. . 1995 Cell 80: 321–330.

  • Snapper CM, Zelazowski P, Rosas FR, Kehry MR, Tian M, Baltimore D and Sha WC. . 1996 J. Immunol. 156: 183–191.

  • Takeda K, Takeuchi O, Tsujimura T, Itami S, Adachi I, Kawai T, Sanjo H, Yoshikawa K, Terada N and Akira S. . 1999 Science 284: 313–316.

  • Tanaka M, Fuentes ME, Yamaguchi K, Durnin MH, Dalrymple SA, Kardy KL and Goeddel DV. . 1999 Immunity 10: 421–429.

  • Wang CY, Mayo MW, Konuluk RG, Goeddel DV and Baldwin Jr AS. . 1998 Science 281: 1680–1683.

  • Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, Ryseck RP, Lira SA and Bravo R. . 1995 Cell 80: 331–340.

  • Weih F, Durham SK, Barton DS, Sha WC, Baltimore D and Bravo R. . 1997 J. Exp. Med. 185: 1359–1370.

  • Weih F, Lira SA and Bravo R. . 1996 Oncogene 12: 445–449.

  • Weih F, Warr G, Yang H and Bravo R. . 1997 J. Immunol. 158: 5211–5218.

  • Wu L, D'Amico A, Winkel KD, Suter M, Lo D and Shortman K. . 1998 Immunity 9: 839–847.

  • Wu MX, Ao Z, Prasad KV, Wu R and Schlossman SF. . 1998 Science 281: 998–1001.

  • Zong WX, Edelstein LC, Chen C, Bash J and Gelinas C. . 1999 Genes Dev. 13: 382–387.

Download references

Acknowledgements

We thank S Mémet and A Israël for communicating results prior to publication. Work in our laboratory is supported by the National Health and Medical Research Council (Australia), the Anti-Cancer Council of Victoria, a Commonwealth AIDS Research Grant (No. 971274), and the International Association for Cancer Research (St Andrews, UK).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gerondakis, S., Grossmann, M., Nakamura, Y. et al. Genetic approaches in mice to understand Rel/NF-κB and IκB function: transgenics and knockouts. Oncogene 18, 6888–6895 (1999). https://doi.org/10.1038/sj.onc.1203236

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203236

Keywords

This article is cited by

Search

Quick links